Literature DB >> 14074349

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

R A O'REILLY, P M AGGELER, L S LEONG.   

Abstract

Entities:  

Keywords:  METABOLISM; PHARMACOLOGY; PHYTONADIONE; PROTHROMBIN TIME; WARFARIN

Mesh：

Substances：

Year:  1963        PMID： 14074349      PMCID： PMC289433          DOI： 10.1172/JCI104839

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Studies on chemical determination of warfar in and coumachlor and their toxicity for dog and swine.

Authors:  H WANNTORP
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1959

2.  Kinetics of drug absorption, distribution, metabolism, and excretion.

Authors:  E NELSON
Journal:  J Pharm Sci       Date:  1961-03       Impact factor: 3.534

3.  The discovery of dicumarol and its sequels.

Authors:  K P LINK
Journal:  Circulation       Date:  1959-01       Impact factor: 29.690

4.  Clinical experience with warfarin sodium.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1958-10-11

5.  Clinical experience with warfarin (coumadin) sodium, a new anticoagulant.

Authors:  B E POLLOCK
Journal:  J Am Med Assoc       Date:  1955-11-12

6.  Studies on disturbution of dicumarol.

Authors:  J P GREEN; E SONDERGAARD; H DAM
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

7.  Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies.

Authors:  S A BERSON; R S YALOW; S S SCHREIBER; J POST
Journal:  J Clin Invest       Date:  1953-08       Impact factor: 14.808

8.  Suicide attempt with warfarin, a bishydroxycoumarin-like rodenticide.

Authors:  R W HOLMES; J LOVE
Journal:  J Am Med Assoc       Date:  1952-03-15

9.  The physiological disposition of dicumarol in man.

Authors:  M WEINER; S SHAPIRO; J AXELROD; J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1950-08       Impact factor: 4.030

10.  Dicumarol labelled with C14.

Authors:  C C LEE; L W TREVOY; J W T SPINKS; L B JAQUES
Journal:  Proc Soc Exp Biol Med       Date:  1950-05
View more
  47 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

Authors:  Andrea Lee; Mark Crowther
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

3.  PHENINDIONE SENSITIVITY.

Authors:  A HOLLMAN; H O WONG
Journal:  Br Med J       Date:  1964-09-19

4.  Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.

Authors:  Radojka M Savic; France Mentré; Marc Lavielle
Journal:  AAPS J       Date:  2010-11-11       Impact factor: 4.009

5.  Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.

Authors:  Joakim Nyberg; Caroline Bazzoli; Kay Ogungbenro; Alexander Aliev; Sergei Leonov; Stephen Duffull; Andrew C Hooker; France Mentré
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

6.  Factor VIIa binding and internalization in hepatocytes.

Authors:  G Hjortoe; B B Sorensen; L C Petersen; L V M Rao
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

7.  Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists.

Authors:  Alexia Blesius; Sylvie Chabaud; Michel Cucherat; Patrick Mismetti; Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Anticoagulant effect and plasma kinetics of fluorophenindione after a single dose in man.

Authors:  J P Tillement; J J Thébault; C Mattei; P d'Athis; C Blatrix
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

Review 9.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

10.  Studies on the coumarin anticoagulant drugs: interaction of human plasma albumin and warfarin sodium.

Authors:  R A O'Reilly
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.